Objective
The opportunity to focus on the production of biopharmaceuticals is often taken from SMEs since huge amount of resources is required for the development of high-producer cell lines. We envision that our parental cell factories will increase the efficiency of cell line engineering and will effectively reduce the time-to-market for mammalian cell-based products. It allows SMEs to leverage their traditional strengths of adaptability and creativity, and to develop novel products for biotechnology industries.
Fields of science
Programme(s)
Call for proposal
H2020-SMEINST-1-2014
See other projects for this call
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
ICOSAGEN CELL FACTORY OU
Address
Eerika Tee 1
61713 Kambja Vald
Estonia
61713 Kambja Vald
Estonia
See on map
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000